2024-06-20
-
Ceutical innovation of LakeShore
benefits the health of humanity -
LakeShore strives for perfection,
pursues excellence,
and creates tomorrow together
To safeguard the human health
Through unremitting long-term efforts, we aim to become a domestic leading and internationally renowned innovative vaccine corporate.
Rigorous and pragmatic, Striving for perfection, Pursuing excellence, Collaborating for mutual benefit.
LakeShore Biopharma (Nasdaq:LSB, formerly YS) is a developer and manufacturer of human-used vaccines and other immune products. At present, the main product under sale is freeze-dried human rabies vaccine (Vero cells), and the cumulative sales of this product since its launch have exceeded a hundred million units.The therapeutic PIKA rabies vaccine (Vero cells) jointly developed by the corporate is a major new drug development project of Ministry of Science and Technolog
